P614 The utility as a biomarker of faecal calprotectin for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis treatment in patients with ulcerative colitis

N Ueno, Y Murakami, T Iwama, T Sasaki, T Kunogi, K Takahashi, K Tanaka, K Ando, S Kashima, Y Inaba, K Moriichi, H Tanabe, M Taruishi, M Fujiya, T Okumura, Journal of Crohn’s and Colitis, Volume 13, Issue Supplement_1, March 2019

Fcal is considered to be a useful and objective predictor of the efficacy of GMA treatment in UC patients and superior to symptomatic scores and blood parameters

https://academic.oup.com/ecco-jcc/article/13/Supplement_1/S423/5300757

apheresis / biomarker / faecal calprotectin / Granulocyte / Monocyte / ulcerative colitis /

Scientific corner

2018

Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study

Takahiro Shimoyama¹, Takayuki Yamamoto², Satoru Umegae¹, Koichi Matsumoto¹ , BMC Gastroenterol. 2018 Aug 1;18(1):120.

Our findings indicate that FC is a relevant biomarker, which is convenient to measure for assessing endoscopic activity and predicting relapse in patients who achieve remission following a course of GMA therapy.

https://pubmed.ncbi.nlm.nih.gov/30068300/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090982/pdf/12876_2018_Article_853.pdf

Clinical remission / cohort / endoscopic activity / faecal calprotectin / immunology / others / predictors / propective / ulcerative colitis /

Contact UsFor more information